The next generation of liposome delivery systems: recent experience with tumor-targeted,sterically-stabilized immunoliposomes and active-loading gradients

Three topics are discussed. Enhanced anti-tumor efficacy of targeted doxorubicin-containing sterically-stabilized liposomes using an anti-beta1 integrin Fab' ligand. Use of tumor targeting with an internalizing ligand to improve the efficacy of a non-leaky cisplatin-containing sterically-stabilized liposome formulation. Formulation variables (remote-loading with dextran ammonium sulfate, rigid lipid bilayer) used to optimize in vivo performance of a liposomal camptothecin analog.     

Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes.

Abstract

The amphipathic anthracycline base doxorubicin (DXR) was accumulated in the aqueous phase of the liposomes where it reached a level as high as 100-fold its concentration in the remote loading medium. Most of the intraliposomal DXR was present in an aggregated state. Efficient (>90%) and stable loading into the liposomes' and ligandoliposomes' aqueous phase was obtained by using gradients of ammonium sulfate in which the ammonium sulfate concentration in the liposomes was higher than its concentration in the extraliposomal medium [(NH₄)₂SO₄)lip. ? [(NH₄)₂SO₄)med.]. The “remote” loading is a result of the DXR exchange with ammonia from (NH₄)₂SO₄. Both the ammonium and sulfate contribute to high level and stability of the loading. The ammonium sulfate gradient method differs from most other chemical approaches used for remote loading of liposomes since it neither requires to prepare the liposomes in acidic pH, nor to alkalinize the extraliposomal aqueous phase. Although most of the intraliposomal DXR is present in an aggregated gel-like state, the drug is bioavailable. This approach permits the preparation of DXR-loaded liposomes of a broad spectrum of types, sizes, and composition, including sterically-stabilized liposomes, immunoliposomes, and sterically-stabilized immunoliposomes. Due to the long shelf stability (>6 mo), no “bedside” remote loading is required immediately before patient treatment, and the formulation is ready for injection. The stable encapsulation of the doxorubicin in an aggregated form also permits freezing and lyophilization of the liposomes with only minimal drug release. The loading by ammonium sulfate gradient approach meets all pharmaceutical requirements; it has brought the clinical use of DXR-loaded sterically-stabilized liposomes to reality.     

The SH3 domain of HS1 protein recognizes lysine-rich polyproline motifs

HS1 is a protein involved in erythroid proliferation and apoptotic cell death, containing several structurally significant motifs including a C-terminal SH3 domain. HPK1 is a member of the Ste20-related kinase family, which contains four proline-rich sequences and is constitutively associated with HS1 in hematopoietic cells. Recombinant fusion protein GST-SH3_HS1 was expressed to assess the binding properties of 16 peptides derived from the HPK1 proline-rich regions. The binding affinities were determined by non-immobilized ligand interaction assay by circular dichroism. Our results revealed that the classical PxxPxK class II binding motif is not sufficient to induce the interaction with the GST-SH3_HS1 domain, an event dependent on the presence of additional basic residue(s) located at the C-terminus of the PxxPxK motif: Lys₋₅ in P2 peptide and Lys₋₈ in P4c peptide. Lys replacement by Arg residues decreases the ligand binding affinity. The finding that both SH3_HS1 domain and full-length HS1 protein bind to P2 peptide with similar affinity demonstrates that the whole protein sequence does not affect the interaction properties of the domain. In silico models of SH3_HS1 as a complex with P2 or P4c highlight the domain residues that interact with the recognition determinants of the peptide ligand and that cooperate in the complex stabilization.     

Synthesis, structures and spectroscopic properties of new 1,2-bis[2-(4-methyl-7-acetylamino-1,8-naphthyridine)]ethylene ligand and its binuclear copper(I) complexes

The synthesis, characterization, spectroscopic properties of a new ligand 1,2-bis[2-(4-methyl-7-acetylamino-1,8-naphthyridine)]ethylene (L) and its two binuclear Cu(I) complexes containing triphenylphosphine (PPh₃) or bis(diphenylphosphino)methane (dppm), [Cu₂(L)(PPh₃)₄](BF₄)₂·2CH₂Cl₂ (1·2CH₂Cl₂) and [Cu₂(L)(dppm)₂](BF₄)₂·4H₂O (2·4H₂O) are reported. The structural investigation of these compounds based on X-ray crystal analysis shows that the copper(I) centers adopt different coordination geometries, O(N)CuP₂⁺ and NCuP₂⁺ for complexes 1 and 2, respectively. Upon irradiation of a degassed organic solution of L at 365 nm, photoinduced isomerization reaction and an intramolecular proton transfer of ligand L were detailed studied by absorption spectral changes. A spectroscopic investigation involving time-dependent density functional theory calculations allows assignment of the excited states that relate to emission and transient absorption spectra. The observed lower-energy absorption bands appearing in the region of 413 and 418 nm for 1 and 2 in dichloromethane are assigned to ligand-to-ligand charge transfer (LLCT, phosphine → napy) transition in nature. Compared with well-structured solid-state emission originating from ππ^∗ transition of ligand L, complexes 1 and 2 exhibit intense room-temperature solid-state emissions with λ_max at 586 and 620 nm, respectively. The energy and the shape of the emission bands are clearly different from that of the ligand, indicating the emissions come from different excited states.     

Structure–activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4′-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity

Novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4′-methylbenzoyl) hydrazone (H₂L) (1) and its two copper(II) complexes have been synthesized. Single-crystal X-ray diffraction studies revealed that the structure of the new copper(II) chloride complex, [Cu(H₂L)Cl₂]·2H₂O (2), is square pyramidal and that of the copper(II) nitrate complex, [Cu(HL)NO₃]·DMF (3), is square planar. In 2, the copper atom is coordinated by the ligand with ONO donor atoms, one chloride ion in the apical position, and the other chloride in the basal plane. In 3, the ligand coordinates as a uninegative tridentate ONO⁻ species and with one nitrate ion in the basal plane. DNA binding experiments indicated that the ligand and copper(II) complexes can interact with DNA through intercalation. Bovine serum albumin binding studies revealed that the compounds strongly quench the intrinsic fluorescence of bovine serum albumin through a static quenching process. Antioxidative activity tests showed that 1 and its copper(II) complexes have significant radical scavenging activity against free radicals. Cytotoxic activities of the ligand and copper(II) complexes showed that the two copper(II) complexes exhibited more effective cytotoxic activity against HeLa and HEp-2 cells than the corresponding ligand. The entire biological activity results showed that the activity order was 1 < 2 < 3.     

Synthesis,characterization and antimicrobial properties of a Co(II)-phthalylsulfathiazolate complex

The reaction between phthalylsulfathiazole (H₂PST), in alkaline aqueous solution, and cobalt(II) nitrate led to a pink solid, [Co(PST)(H₂O)₄] (1), which was characterized by elemental and thermogravimetric analysis; FT-IR, Raman and diffuse reflectance spectra. Spectroscopic data reveal that the ligand would be doubly deprotonated and that the Co(II) ion environment is a distorted octahedral one. (1) showed antibacterial activity similar to the ligand.     

Interaction of Adrenal Cell Membrane Receptors with Dimers of Corticotropin Fragments and with Poly-L-Lysine

Abstract

Polycationic peptides are demonstrated to interact with the membrane receptors of the adrenal cell as judged from their effect on steroidogenesis. The corticotropin fragments ACTH_7-24 and ACTH_11-24, when covalently dimerized at their C-termini, strongly antagonize both corticotropin- and angiotensin II -induced steroidogenesis, while dimerized ACTH_1-24 behaves as a mixed agonist/antagonist. A quantitative analysis of the antagonistic potencies shows that the measured effects are consistent with the prediction that electrostatically controlled accumulation of the charged ligand at the cell surface is an important factor in the overall ligand/receptor interaction. Similar antagonizing effects of poly-L-lysine provide further support for this hypothesis.     

Studies on Non-Covalent Interaction of Coumarin Attached Pyrimidine and 1-Methyl Indole 1,2,3 Triazole Analogues with Intermolecular Telomeric G-Quadruplex DNA Using ESI-MS and Spectroscopy

In the present study, electrospray ionization mass spectrometry (ESI-MS) and spectroscopy have been used to evaluate the non-covalent interaction, stoichiometry, and selectivity of two synthetic coumarin-attached nucleoside and non-nucleoside 1,2,3-triazoles, namely, (1-(5-(hydroxymethyl)-4-(4-((2-oxo-2H-chromen-4-yloxy)methyl)-1H-1,2,3-triazol-1-yl)tetrahydro-furan-2-yl)5-methyl pyrimidine-2,4(1H,3H)-dione (Tr1) and 4-((1-((-1-methyl-1H-indol-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methoxy)-2H-chromen-2-one (Tr2) with two different human telomeric intermolecular G-quadruplex DNA structures formed by d(T₂AG₃) and d(T₂AG₃)₂ sequences. ESI-MS studies indicate that Tr1 specifically interacts with four-stranded intermolecular parallel quadruplex complex, whereas Tr2 interacts with two hairpin as well as four-stranded intermolecular parallel quadruplex complexes. UV–Visible spectroscopic studies suggest that Tr1 and Tr2 interact with G-quadruplex structure and unwind them. Job plots show that stoichiometry of ligand:quadruplex DNA is 1:1. Circular dichroism (CD) studies of G-quadruplex DNA and Tr1/Tr2 ligands manifest that they unfold DNA on interaction. Fluorescence studies demonstrate that ligand molecules intercalate between the two stacks of quadruplex DNA and non-radiative energy transfer occurs between the excited ligand molecules (donor) and quadruplex DNA (acceptor), resulting in enhancement of fluorescence emission intensity. Thus, these studies suggest that nucleoside and non-nucleoside ligands efficiently interact with d(T₂AG₃) and d(T₂AG₃)₂ G-quadruplex DNA but the interaction is not alike with all kinds of quadruplex DNA, this is probably due to the variation in the pharmacophores and structure of the ligand molecules.     

Crystal and solution structure of oxo rhenium(V) complexes with cysteine and cysteine methyl ester

 The monooxo rhenium(V) complexes of cysteine (complex 1) and cysteine methyl ester (complex 2) were synthesised via a ligand exchange reaction starting from gluconatooxorhenium(V). Unexpectedly, the obtained oxorhenium(V) complex with cysteine methyl ester (2) was partially saponified. Both complexes were characterised by common analytical techniques in their solid state. Thus, an octahedral complex structure with 2(NH₂,S) co-ordination in the equatorial plane and one carboxyl group bound trans to the oxo group is proven for complex 2 by X-ray diffraction. Furthermore, the existence of a dioxo species at higher pH was proven for the first time with this type of ligand by determining the nearest co-ordination sphere of the rhenium centre in solution at a pH of 12 using extended X-ray absorption fine structure spectroscopy. Received: 20 July 1998 / Accepted: 2 December 1998     

Recent Progress in the Purification of Adenosine Receptors

Abstract

A₁ adenosine receptors were purified to an apparent homogeneity from rat brain and testicular membranes by a novel affinity chromatography system using xanthine amine congener (XAC) as an immobilized ligand. This affinity chromatography was also useful for the purification of human brain A1 adenosine receptor.     

The Flexibility of the Nucleic Acids: (III) The Interaction of an Aliphatic Diamine,Putrescine, with Flexible B-DNA

Abstract

A theoretical modelling of the interaction of putrescine (H⁺ ₃N—(CH₂)₄—(-N⁺H₃) with DNA is carried out, introducing two new features which make the simulation of this interaction considerably more realistic. Firstly, the DNA to which putrescine is bound is fully flexible and thus able to respond to the distorting influence of the ligand. Secondly, the effect of changing the ratio of DNA base pairs per bound ligand is explicitly modelled. In this way. we have been able to confirm the experimentally known preference of putrescine binding with AT base pairs in B-DNA, but we also show, through the new features introduced, that the nature of the binding site of the ligand and the resulting impact on DNA conformation is strongly modified by the ligand binding density.     

Spectral analysis and in vitro cytotoxicity profiles of novel organotin(IV) esters of 2-maleimidopropanoic acid

Six novel triorganotin(IV) 2-maleimidopropanoato complexes: R₃SnOCOCH₃(CH)(COCH)₂, (R: Me(1), Et(2), n-Pr(3), n-Bu(4), Ph(5), Bz(6) have been synthesized. Their solid-state configuration has been determined by FT IR and ^119mSn Mössbauer spectroscopy. The tin(IV) atom is five-coordinated in all the complexes with 2-maleimidopropanoic acid behaving as a monoanionic bidentate ligand coordinating the tin(IV) atom through a chelating or bridging carboxylate group. The solution-state configuration has been elucidated by means of ¹H-, ¹³C- and ¹¹⁹Sn-NMR spectroscopy which assigned a tetrahedron. Elemental analysis and FAB MS data also supported a 1:1 metal to ligand stoichiometry. The title complexes have been screened in vitro for anti-tumour, anti-fungal, anti-leishmanial and urease inhibition activities and displayed promising results.     

Reduction in the urinary aflatoxin M1 biomarker as an early indicator of the efficacy of dietary interventions to reduce exposure to aflatoxins

Abstract

Aflatoxin B₁ is a persistent public health issue in Ghana. Assessment of AFB₁ intervention efficacy is currently dependent on long-term biomarkers. This study was designed to determine whether daily AFM₁ biomarker levels could be utilized as an early detection method for intervention efficacy. Participants were treated with a refined calcium montmorillonite clay (UPSN) or a placebo (calcium carbonate) in a crossover study. Urine samples were assessed for AFM₁ levels daily. UPSN treatment reduced AFM₁ biomarkers by 55% compared to the placebo. This is the first study to show that daily urinary AFM₁ levels can be used as a biomarker of internal aflatoxin B₁ exposure in short-term intervention trials to determine efficacy.     

A NEW COLLOIDAL LIPIDIC SYSTEM FOR GENE THERAPY

ABSTRACT

A novel type of liposomal vector for gene therapy is described (Artificial Virus Particles; AVPs). This vector is based on the composition of retroviral envelopes, serum-resistant and non-toxic and smaller than 200 nm in size. The DNA is condensed using low molecular weight branched PEI. Equipment of these particles with a cyclic RGD peptide ligand as targeting device renders them selective for tumor endothelial and melanoma cells expressing high levels of α_vβ₃-integrins, and allows for an efficient delivery of the enclosed genetic material. The specificity of the vector system for melanoma cells could be further improved by using a melanocyte-specific tyrosinase promoter to drive transgene expression.     

A comparative SAR study of thrombin receptor derived non peptide mimetics: Importance of phenyl/guanidino proximity for activity

Summary Thrombin, the most potent physiological platelet agonist interacts with cells through a specific G protein-coupled receptor which has been cloned and sequenced. Synthetic thrombin receptor peptides (TRAPS) comprising the first 5 amino acids (SFLLR and SFLLR-NH₂) of the new N-terminus tethered ligand of the thrombin receptor that is generated by thrombin's proteolytic activity were found to cause full platelet aggregation. During the screening of novel thrombin receptor derived non-peptide mimetics in the platelet aggregation assay we found that 1-phenylacetyl-4-(6-guanidohexanoyl)-piperazine (1) and 1-(6-guanidohexanoyl)-4-(phenylacetylamidomethyl)-piperidine (2) exertedin vitro antagonist activities (56% and 40% correspondingly) as it is depicted by the platelet aggregation assay. Using Molecular Modeling, the synthetic compounds were overlayed with SFFLR. All three superimposed low energy structures had Phe and Arg aminoacids in spatial close proximity. The superimposition results revealed that1 resembled more the stereoelectronic environment of SFLLR than2. This difference may be related to their different antagonist efficacy.     

Copper binding ability of the extracellular organic matter released by Skeletonema costatum

Abstract

The copper complexing ability of the exudates produced during the exponential growth phase by Skeletonema costatum has been investigated by a ligand-competition technique involving copper sorption onto C-18 Sep-Pak cartridges. Two ligands with different affinity for copper were required for the best fit of the copper complexation data in seawater with and without exudates: a strong ligand with a log K close to 13 and a weaker ligand with a log K close to 9. The culture increased both L₁ and L₂ ligand concentrations, already present in seawater, by a factor close to 4 after the first 72 hours of growth. The presence of class 1 stronger ligands in copper binding organics produced by the diatom is discussed in relation to natural copper speciation in the sea.     

Comparative Study between Histochemical and Biochemical Estimation of Estrogen Receptors in Tumors

Abstract

Sucrose gradient analysis (SDGC) was compared with histofluoroassay, using 17ß -Estradiol-6-carboxymethyloxime-bovine serum albumin-fluolescein isothiocyanate (E₂-BSA-FITC) as fluorescent ligand, for the estimation of estrogen receptors (ER) in human breast tumors. No correlation was seen between fluorescent ligand bindig capacity by the tumoral tissues on the one hand and ER levels estimated by SDGC on the other hand. The fluorescent ligand had a lower affinity for the receptor than estradiol itself and was contaminated with free estradiol. It was concluded that the absence of correlation between both techniques was for the greatest part due to unspecific binding of E₂-BSA-FITC.     

CDP7657, an anti-CD40L antibody lacking an Fc domain,inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

IntroductionCD40 ligand (CD40L) blockade has demonstrated efficacy in experimental autoimmune models. However, clinical trials of hu5c8, an anti-human CD40L IgG₁ antibody, in systemic lupus erythematosus (SLE) were halted due to an increased incidence of thrombotic events. This study evaluated CDP7657, a high affinity PEGylated monovalent Fab'' anti-CD40L antibody fragment, to assess whether an Fc-deficient molecule retains efficacy while avoiding the increased risk of thrombotic events observed with hu5c8.MethodsThe potency and cross-reactivity of CDP7657 was assessed in in vitro assays employing human and non-human primate leukocytes, and the capacity of different antibody formats to activate platelets in vitro was assessed using aggregometry and dense granule release assays. Given the important role CD40L plays in regulating humoral immunity, in vivo efficacy was assessed by investigating the capacity of Cynomolgus monkeys to generate immune responses to the tetanus toxoid antigen while the potential to induce thrombotic events in vivo was evaluated after repeat dosing of antibodies to Rhesus monkeys. A PEGylated anti-mouse CD40L was generated to assess efficacy in the New Zealand Black/White (NZB/W) mouse model of SLE.ResultsCDP7657 dose-dependently inhibited antigen-specific immune responses to tetanus toxoid in Cynomolgus monkeys, and in contrast to hu5c8, there was no evidence of pulmonary thrombovasculopathy in Rhesus monkeys. Aglycosyl hu5c8, which lacks Fc receptor binding function, also failed to induce thrombotic events in Rhesus monkeys. In vitro experiments confirmed that antibody constructs lacking an Fc, including CDP7657, did not induce human or monkey platelet activation. A PEGylated monovalent Fab'' anti-mouse CD40L antibody also inhibited disease activity in the NZB/W mouse model of SLE after administration using a therapeutic dosing regimen where mice received antibodies only after they had displayed severe proteinuria.ConclusionsThese findings demonstrate for the first time that anti-CD40L antibodies lacking a functional Fc region do not induce thrombotic events in Rhesus monkeys and fail to activate platelets in vitro but, nevertheless retain pharmacological activity and support the investigation of CDP7657 as a potential therapy for systemic lupus erythematosus and other autoimmune diseases.

Electronic supplementary material

The online version of this article (doi:10.1186/s13075-015-0757-4) contains supplementary material, which is available to authorized users.     

Duplex Stabilization by DNA-Hoechst 33258 Conjugates: Effects of Base Pair Mismatches

Abstract

Three types of DNA-Hoechst conjugates are examined for duplex stability in the presence of single-site base pair mismatches. Two of the complexes have the Hoechst ligand tethered to an internal phosphate residue, while the third complex employs terminally labeled conjugate. The presence of the mismatched base pair reduces the T_m values for the non-conjugate duplexes as is expected. Addition of the conjugated Hoechst ligand enhances the T_m values for the mismatched duplexes, but these values remain significantly below that obtained for the native conjugated duplex. While stabilization by the tethered ligand is observed for both cognate and non-cognate sequences, the differences suggest that significant sequence selectivity is still apparent for these conjugates.     

Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor (GPCR)

The concept of “biased agonism” arises from the recognition that the ability of an agonist to induce a receptor-mediated response (i.e. “efficacy”) can differ across the multiple signal transduction pathways (e.g. G protein and β-arrestin (βarr)) emanating from a single GPCR. Despite the therapeutic promise of biased agonism, the molecular mechanism(s) whereby biased agonists selectively engage signaling pathways remain elusive. This is due in large part to the challenges associated with quantifying ligand efficacy in cells. To address this, we developed a cell-free approach to directly quantify the transducer-specific molecular efficacies of balanced and biased ligands for the angiotensin II type 1 receptor (AT₁R), a prototypic GPCR. Specifically, we defined efficacy in allosteric terms, equating shifts in ligand affinity (i.e. K_Lo/K_Hi) at AT₁R-G_q and AT₁R-βarr2 fusion proteins with their respective molecular efficacies for activating G_q and βarr2. Consistent with ternary complex model predictions, transducer-specific molecular efficacies were strongly correlated with cellular efficacies for activating G_q and βarr2. Subsequent comparisons across transducers revealed that biased AT₁R agonists possess biased molecular efficacies that were in strong agreement with the signaling bias observed in cellular assays. These findings not only represent the first measurements of the thermodynamic driving forces underlying differences in ligand efficacy between transducers but also support a molecular mechanism whereby divergent transducer-specific molecular efficacies generate biased agonism at a GPCR.